跳至主要内容
临床试验/ISRCTN96327523
ISRCTN96327523已完成未知

Optimal blood management in elective orthopaedic surgery: the Transfusion Op Maat (TOMaat) study

eiden University Medical Centre (LUMC) (Netherlands)0 个研究点目标入组 3,689 人开始时间: 2005年12月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
3,689

研究概览

简要总结

2020 results in https://pubmed.ncbi.nlm.nih.gov/32963331/ (added 26/01/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • All orthopedic patients of 18 years and older being considered for a primary or revision total knee replacement (TKR) or total hip replacement (THR).

排除标准

  • 1. Refusal of allogeneic blood
  • 2. Pregnancy
  • 3. Patients with uncontrolled hypertension
  • 3. Cardiac instability
  • 4. Recent CVA
  • 5. Symptomatic atherosclerosis
  • 6. Sickle cell anaemia
  • 7. Cancer in the wound area
  • 8. Unsuitability for peri-operative anticoagulation prophylaxis
  • 9. Known allergy to erythropoietin
  • 10. Infected prosthesis or wound

研究者

发起方
eiden University Medical Centre (LUMC) (Netherlands)

相似试验